Jeffrey Simmons N.'s most recent trade in Elanco Animal Health Inc was a trade of 185 Deferred Stock Units done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 185 | 17,035 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 193 | 16,849 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 200 | 16,655 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 206 | 16,455 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 214 | 16,249 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 284 | 16,034 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2025 | 326 | 15,750 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 302 | 15,424 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 262 | 15,121 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 8,902 | 14,858 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 556,587 | 556,587 | - | - | Employee Stock Option (right to buy) | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 265,252 | 1,802,379 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,891 | 14,891 | - | - | Deferred Stock Units (Match) | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.17 per share. | 01 Mar 2025 | 75,721 | 1,537,127 (0%) | 0% | 11.2 | 845,804 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 251 | 5,955 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 449,408 | 1,808,688 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.24 per share. | 19 Feb 2025 | 195,840 | 1,612,848 (0%) | 0% | 11.2 | 2,201,242 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 240 | 5,704 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 229 | 5,464 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 242 | 5,234 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey Simmons N. | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 229 | 4,992 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 228 | 4,762 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 209 | 4,534 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 198 | 4,324 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 219 | 4,126 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 213 | 3,906 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 188 | 3,693 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2024 | 196 | 3,504 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 183 | 3,307 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2024 | 190 | 3,123 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Purchase of securities on an exchange or from another person at price $ 13.01 per share. | 12 Aug 2024 | 100,000 | 145,000 (0%) | 0% | 13.0 | 1,300,610 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 212 | 2,933 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 214 | 2,721 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 200 | 2,506 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 191 | 2,306 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 153 | 2,114 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 156 | 1,960 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 161 | 1,804 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 204 | 1,642 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2024 | 213 | 1,438 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 177 | 1,224 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2024 | 175 | 1,046 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 168 | 871 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.99 per share. | 05 Mar 2024 | 11,012 | 1,356,455 (0%) | 0% | 16.0 | 176,082 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 408,164 | 408,164 | - | - | Employee Stock Option(right to buy) | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 187,150 | 1,415,892 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.03 per share. | 01 Mar 2024 | 48,425 | 1,367,467 (0%) | 0% | 16.0 | 776,253 | Common Stock |
| Elanco Animal Health Inc | N. Simmons Jeffrey | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 148,084 | 1,293,269 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey Simmons N. | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 27 Feb 2024 | 64,527 | 1,228,742 (0%) | 0% | 16.5 | 1,062,114 | Common Stock |
| Elanco Animal Health Inc | N. Simmons Jeffrey | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 169 | 703 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey Simmons N. | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 173 | 533 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | N. Simmons Jeffrey | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 182 | 360 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 178 | 178 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Purchase of securities on an exchange or from another person at price $ 9.60 per share. | 10 Mar 2023 | 15,000 | 45,000 (0%) | 0% | 9.6 | 143,972 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.10 per share. | 05 Mar 2023 | 10,696 | 1,142,569 (0%) | 0% | 11.1 | 118,726 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 316,386 | 1,291,147 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 02 Mar 2023 | 137,882 | 1,153,265 (0%) | 0% | 11.0 | 1,518,081 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 567,952 | 567,952 | - | - | Employee Stock Option (right to buy) | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 248,668 | 991,037 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 01 Mar 2023 | 12,662 | 742,369 (0%) | 0% | 11.3 | 142,574 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 01 Mar 2023 | 9,149 | 974,761 (0%) | 0% | 11.0 | 100,730 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Purchase of securities on an exchange or from another person at price $ 14.54 per share. | 09 Sep 2022 | 30,000 | 30,000 (0%) | 0% | 14.5 | 436,146 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.95 per share. | 05 Mar 2022 | 10,688 | 752,986 (0%) | 0% | 28.0 | 298,730 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 234,160 | 234,160 | - | - | Employee Stock Option(right to buy) | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 88,114 | 777,584 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.00 per share. | 01 Mar 2022 | 8,879 | 763,674 (0%) | 0% | 29 | 257,491 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, PRESIDENT, CEO AND DIRECTOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 01 Mar 2022 | 5,031 | 772,553 (0%) | 0% | 28.9 | 145,597 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 229,655 | 782,418 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 22 Feb 2022 | 92,948 | 689,470 (0%) | 0% | 26.0 | 2,414,789 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.66 per share. | 20 Oct 2021 | 15,814 | 552,763 (0%) | 0% | 33.7 | 532,299 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Purchase of securities on an exchange or from another person at price $ 29.70 per share. | 11 Aug 2021 | 16,850 | 568,577 (0%) | 0% | 29.7 | 500,445 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 74,374 | 551,727 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.34 per share. | 01 Mar 2021 | 8,879 | 477,353 (0%) | 0% | 32.3 | 287,147 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.65 per share. | 01 Mar 2021 | 4,883 | 486,232 (0%) | 0% | 33.7 | 164,313 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 89,902 | 530,295 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.58 per share. | 22 Feb 2021 | 39,180 | 491,115 (0%) | 0% | 30.6 | 1,198,124 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.81 per share. | 01 Feb 2021 | 14,965 | 440,393 (0%) | 0% | 29.8 | 446,107 | Common Stock |
| Elanco Animal Health Inc | Jeffrey N. Simmons | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.67 per share. | 31 Dec 2020 | 33,759 | 455,358 (0%) | 0% | 30.7 | 1,035,389 | Common Stock |